Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis
Author:
Zhang Shanshan1, Akmar Lily Zainal1, Bailey Freddie1, Rath Barbara A2, Alchikh Maren2, Schweiger Brunhilde3, Lucero Marilla G4, Nillos Leilani T4, Kyaw Moe H5, Kieffer Alexia6, Tong Sabine7, Campbell Harry1ORCID, Beutels Philippe8, Nair Harish19ORCID, Nair Harish, Campbell Harry, Shi Ting, Zhang Shanshan, Li You, Openshaw Peter, A Wedzicha Jadwicha, R Falsey Ann, Miller Mark, Beutels Philippe, Antillon Marina, Bilcke Joke, Li Xiao, Bont Louis, Pollard Andrew, Molero Eva, Martinon-Torres Federico, Heikkinen Terho, Meijer Adam, Fischer Thea Kølsen, van den Berge Maarten, Giaquinto Carlo, Mikolajczyk Rafael, Hackett Judy, Tafesse Eskinder, Lopez Antonio Gonzalez, Dieussaert Ilse, Dermateau Nadia, Stoszek Sonia, Gallichan Scott, Kieffer Alexia, Demont Clarisse, Cheret Arnaud, Gavart Sandra, Aerssens Jeroen, Wyffels Veronique, Cleenewerck Matthias, Fuentes Robert, Rosen Brian, Nair Harish, Campbell Harry, Shi Ting, Zhang Shanshan, Li You, Openshaw Peter, A Wedzicha Jadwicha, R Falsey Ann, Miller Mark, Beutels Philippe, Antillon Marina, Bilcke Joke, Li Xiao, Bont Louis, Pollard Andrew, Molero Eva, Martinon-Torres Federico, Heikkinen Terho, Meijer Adam, Fischer Thea Kølsen, van den Berge Maarten, Giaquinto Carlo, Mikolajczyk Rafael, Hackett Judy, Tafesse Eskinder, Lopez Antonio Gonzalez, Dieussaert Ilse, Dermateau Nadia, Stoszek Sonia, Gallichan Scott, Kieffer Alexia, Demont Clarisse, Cheret Arnaud, Gavart Sandra, Aerssens Jeroen, Wyffels Veronique, Cleenewerck Matthias, Fuentes Robert, Rosen Brian,
Affiliation:
1. Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom 2. Vienna Vaccine Safety Initiative, Berlin, Germany 3. National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany 4. Research Institute for Tropical Medicine, Alabang, Muntinlupa City, Philippines 5. Sanofi Pasteur, Swiftwater, Pennsylvania, USA 6. Sanofi Pasteur, Lyon, France 7. IVIDATA Stats, Levallois-Perret, France 8. Universiteit Antwerpen, Antwerpen, Belgium 9. ReSViNET Foundation, Zeist, The Netherlands
Abstract
Abstract
Background
Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infection (ALRI) in young children aged <5 years.
Methods
We aimed to identify the global inpatient and outpatient cost of management of RSV-ALRI in young children to assist health policy makers in making decisions related to resource allocation for interventions to reduce severe morbidity and mortality from RSV in this age group. We searched 3 electronic databases including Global Health, Medline, and EMBASE for studies reporting cost data on RSV management in children under 60 months from 2000 to 2017. Unpublished data on the management cost of RSV episodes were collected through collaboration with an international working group (RSV GEN) and claim databases.
Results
We identified 41 studies reporting data from year 1987 to 2017, mainly from Europe, North America, and Australia, covering the management of a total of 365 828 RSV disease episodes. The average cost per episode was €3452 (95% confidence interval [CI], 3265–3639) and €299 (95% CI, 295–303) for inpatient and outpatient management without follow-up, and it increased to €8591(95% CI, 8489–8692) and €2191 (95% CI, 2190–2192), respectively, with follow-up to 2 years after the initial event.
Conclusions
Known risk factors (early and late preterm birth, congenital heart disease, chronic lung disease, intensive care unit admission, and ventilator use) were associated with €4160 (95% CI, 3237–5082) increased cost of hospitalization. The global cost of inpatient and outpatient RSV ALRI management in young children in 2017 was estimated to be approximately €4.82 billion (95% CI, 3.47–7.93), 65% of these in developing countries and 55% of global costs accounted for by hospitalization. We have demonstrated that RSV imposed a substantial economic burden on health systems, governments, and the society.
Funder
Innovative Medicines Initiative 2 Joint Undertaking European Union’s Horizon 2020 research and innovation programme and EFPIA Sanofi Pastuer
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|